ISSN: 2332-0877

Journal des maladies infectieuses et de la thérapie

Accès libre

Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Abstrait

Multidrug Resistant Tuberculosis: Still a Problem in the Russian Federation

Dronova Tatiana Alekseyevna, Rodrigo Sardenberg, Sofia Wagemaker Viana, Gabriel Antonio Roberto, Polyakov Dmitry Viktorovich

Objective: Tuberculosis is a primitive disease that is still quite prevalent today. Multidrug resistant tuberculosis is the main cause of death by tuberculosis in Russia. This study aims to present results on tuberculosis and multidrug resistant tuberculosis in Russia.

Methods: A systematic review was conducted to identify studies that investigated multidrug resistant tuberculosis in Russia, using the databases PubMed/NCBI, WHO, Google Scholar, CyberLeninka, XXX National Congress on Respiratory Diseases in Moscow, and Russian Ministry of Health databases from the last five years. Originally 684 studies were recognized in the databases searched, of which 40 articles were selected for the current study.

Results: According to the World Health Organization, Russia was the country with the most tuberculosis cases in the world, although these figures have decreased over the past 21 years. Instead, the cases of multidrug resistant tuberculosis are increasing: 37,357 people in 2015 against 34,832 in 2012.

Conclusion: We observed a high rate of multidrug resistant tuberculosis in Russia due to mistakes such as lack of drugs and low adherence to treatment.